Results 191 to 200 of about 28,495,701 (282)
Reductions in Advanced Chronic Liver Disease Among People Who Inject Drugs: The ETHOS Engage Study
Liver International, Volume 46, Issue 12, December 2026.ABSTRACT Background and Aims
Liver disease is a significant risk for people who inject drugs due to the high burden of hepatitis C virus (HCV). There is limited data on the impact of the direct‐acting antiviral (DAA) therapy era on liver disease among people who inject drugs.Anna Conway, Heather Valerio, Jessie Payne, David Silk, Alison D. Marshall, Marianne Martinello, Shane Tillakeratne, Putu Novi Arfirsta Dharmayani, Andrew Milat, Janaki Amin, Phillip Read, Louisa Degenhardt, Annabelle Stevens, Jeremy Hayllar, Michael Christmass, Victoria Cock, Jessica Doumany, Jason Grebely, Gregory J. Dore, on behalf of the ETHOS Engage Study Group, Amanda Erratt, Kyle Leadbeatter, Carla Treloar, Adrian Dunlop, Carolyn Murray, Mary Ellen Harrod, Mel Rhagnath, Clarke Scott, Vicky Cock, Jess Doumany, Dominic Mounsey, Maria Martinez, Amanda Erratt, Nadine Ezard, Craig Rodgers, David Reid, Carla Gorton, Jeremy Hayllar, Thao Lam, Adrian Dunlop, Prasun Datta, Alex Wade, Sally Spruce, Vicki Cock, Sarah Michelmore, Mark Cornwell, Krista Zohrab, Kate Salisbury, Patricia Collie, Craig Connelly, Angela Cooper, Mark Montebello, Chris Gough, Robert Cherry, Julie Dyer, Shikha Agrawal, Elke Press, Alice Wang, Teodora Zanesheva‐Karamanlieva, Eleanor Kessler, Nadine Horasak, Rhondda Lewis, Astrid Carthew, Daniel Morris, Kathy Donohue, Faith Bassett, Kathy Griffiths, Jason Dalla Lana, Sue Shin, Kylie Page, Julie Luff, Rebecca Hyland, Jane Booty, Todd McKillop, Connie Graf, Adele Hampson, Siyu Qian, Danielle Brown, Amber Lautier, Cate Curran, Peta McAlister, Peter Warburton, Rachel Pollard, Daniel Pekin‐Stores, Jessica Rees, Danielle Gaudiosi, Tammy Raikko, Martina Camitz, Corrie Brandsma‐McGrath, Emma Harkins, Nicole Stuart, Coby‐Lea Chalker, Carly Harvey, Edwin Christopher, David Khalil, Kerry McMorrow, Melissa Wellman, Carina Burns, Ravina Raidu, Kylie Stolzenhein, Wanda Brabender, Kelly Somes, Gary Keogh, Isabella Conwell, Nargis Abram, Rick Turner, Stuart Larter, Fiona Goodberg, Jennifer Luksza, Meryem Jefferies, Michelle Hall, Susan Hazelwood, Charlotte Ismay, Antoni Pazeski, Bettina Sweetman, Michelle Gallagher, Cecily Willis, Amanda Brown, Belinda McClurg, Cherie Mincham, Kali Barlow, Anita Hoskins, Laura Johnson, Courtney Priestley, Amie Johns, Shane Moore, Kerrie‐Ann Lahrs, Julie Markham, Jacky Talmet, Sandy Dunn, Amanda Mitchell, Lauren Bright, May Lee, Alcohol Services, Bronwyn Gordon, Blair Brewerton, Michael Wallace, Andrew McKinnon, Fionnuala Smyth, Lisa Snell, Elizabeth Laing, Martin Clark, Justin Dorigo, Louise Carman, Toni Hamilton, Ching Tan, Deidre O'Shea, Brent Fergusson, Bonny Puszka, Gai Duncan, Fiona Baker, Jayde Walsh, Leeann Walsh, Hannah Cook, Natasha Nikolic, Louise Hughes, Julia Bitmead, Dean Wang, Kareen Tait, Sav Gollapally, Cáitleen Moloney, Sarah Ahmed +161 morewiley +1 more sourceEmerg Infect Dis
Coccidioidomycosis, a mild flulike illness in approximately 40% of infected persons, progresses to severe pulmonary or disseminated disease in 1% to 10% of symptomatic cases. We examined host genetic influences on disease severity among class II HLA loci core Polymer‐Modulated Fructose Dehydrogenase Bioelectrocatalysis on Highly Porous Gold Electrodes for Direct Electron Transfer Fructose Sensing in Fermentation Broth
ChemElectroChem, Volume 13, Issue 22, 17 November 2026.Highly porous gold electrodes are coupled with polymer interlayers to control fructose dehydrogenase orientation and direct electron transfer. Poly(acrylic acid) provides the most effective interface, enabling low‐potential fructose oxidation, micromolar detection, and exceptional long‐term stability in fermentation broth.Verdiana Marchianò, Alessandra Cimino, Angelo Tricase, Yohei Suzuki, Eole Fukawa, Keisei Sowa, Angela Stefanachi, Francesco Leonetti, Eleonora Macchia, Nicoletta Ditaranto, Luisa Torsi, Paolo Bollella +11 morewiley +1 more sourcePhase II Study of Posttransplant Cyclophosphamide‐Based Graft‐Versus‐Host Disease Prophylaxis After HLA‐Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort
American Journal of Hematology, Volume 101, Issue 11, Page 2827-2835, November 2026.ABSTRACT
Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...Brian C. Shaffer, Monzr M. Al Malki, Antonio Martin Jimenez Jimenez, Joseph Stanek, Stephanie Bo‐Subait, Brent R. Logan, Jianqun Kou, Erin Leckrone, Heather E. Stefanski, Stephen R. Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Dipenkumar Modi, Farhad Khimani, Mehdi Hamadani, Martin Maiers, Rachel Cook, Karen Ballen, Javier Bolaños‐Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William J. Hogan, Ran Reshef, Satyajit Kosuri, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Won Choi, Larisa Broglie, Jeffery J. Auletta, Bronwen E. Shaw, Steven M. Devine, Mahasweta Gooptu +38 morewiley +1 more sourceQuinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction
Chemistry &Biodiversity, Volume 23, Issue 11, November 2026.A series of title compounds was synthesized, with 6e and 6k exhibiting the lowest IC50 values against MCF‐7, HeLa, and HepG2 cancer cell lines. Molecular docking and dynamics revealed strong binding to the adenosine A1 receptor (ΔG = –9.02 and –9.24 kcal/mol).Bangar Reddy Vancha, Mandapalli Sreeshitha, Shaik Farheen Banu, Kamala Prasad Vasikarla, Satyanarayana Swamy Vyshnava, Mukhriddin Makhkamov, Parthiban Marimuthu, Jamoliddin Razzokov, Aminul Islam, Peddiahgari Vasu Govardhana Reddy +9 morewiley +1 more source